The First M&A in Aging Bioinformatics: Insilico Medicine and InSilicoScreen Join Forces to Take …

BALTIMORE, Md., Dec. 10, 2015 (GLOBE NEWSWIRE) — via PRWEB – “The most valuable assets in bioinformatics companies are its people and at Insilico Medicine we constantly hire top talent through hackathons, challenges and competitions. Quentin Vanhaelen is an army of one who has developed a vertically-integrated system which synthesises data, performs complex simulations using manually-curated and automatically-annotated databases of molecular interactions primarily in Fortran, and produces impressive LaTeX reports. We are happy to have him join our team”, said Alex Zhavoronkov, PhD, CEO of Insilico Medicine, Inc.Since 2013, under Dr. Vanhaelen’s leadership, scientists at InSilicoScreen have assembled large databases of kinetic protein interactions and built sophisticated signal transmission, regulation of cell metabolism, autophagy, cell cycle and other models. The sole aim was to build models of human aging and…


Link to Full Article: The First M&A in Aging Bioinformatics: Insilico Medicine and InSilicoScreen Join Forces to Take …